M C Camargo
Overview
Explore the profile of M C Camargo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arenas A, Serrano C, Quinones L, Harris P, Sandoval M, Lavanderos M, et al.
Sci Rep
. 2019 Dec;
9(1):20070.
PMID: 31882676
Helicobacter pylori (H. pylori) eradication using standard triple therapy (STT) with proton pump inhibitors (PPI), amoxicillin and clarithromycin (CLA) has been the standard in Latin America. However, CLA resistance is...
2.
Bosques-Padilla F, Remes-Troche J, Gonzalez-Huezo M, Perez-Perez G, Torres-Lopez J, Abdo-Francis J, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2018 Jun;
83(3):325-341.
PMID: 29941237
Important advances have been made since the last Mexican consensus on the diagnosis and treatment of Helicobacter pylori (H. pylori) infection was published in 2007. Therefore, the Asociación Mexicana de...
3.
Song M, Camargo M, Weinstein S, Murphy G, Freedman N, Koshiol J, et al.
Aliment Pharmacol Ther
. 2017 Dec;
47(4):494-503.
PMID: 29243850
Background: Serum pepsinogen 1 (SPG1) and anti-Helicobacter pylori serology have been used for gastric risk stratification in Asia. Aim: To assess utility of these markers in a Western population. Methods:...
4.
Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo M, Dar N, et al.
Ann Oncol
. 2017 Sep;
28(9):2086-2093.
PMID: 28911061
The International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI) have initiated a series of cancer-focused seminars [Scelo G, Hofmann JN, Banks RE et al....
5.
Figueiredo C, Camargo M, Leite M, Fuentes-Panana E, Rabkin C, Machado J
Curr Top Microbiol Immunol
. 2017 Jun;
400:E1.
PMID: 28608027
No abstract available.
6.
Figueiredo C, Camargo M, Leite M, Fuentes-Panana E, Rabkin C, Machado J
Curr Top Microbiol Immunol
. 2017 Jan;
400:277-304.
PMID: 28124158
Gastric cancer is the fifth most incident and the third most common cause of cancer-related death in the world. Infection with Helicobacter pylori is the major risk factor for this...
7.
Sung H, Camargo M, Yu K, Weinstein S, Morgan D, Albanes D, et al.
Genes Immun
. 2015 Aug;
16(8):567-70.
PMID: 26312625
A genome-wide association study among Europeans related polymorphisms of the Toll-like receptor (TLR) locus at 4p14 and the Fcγ receptor 2a locus at 1q23.3 to Helicobacter pylori serologic status. We...
8.
Camargo M, Rabkin C, Appel N, Hollenbeck A
Cancer Causes Control
. 2015 Jun;
26(9):1361.
PMID: 26092380
No abstract available.
9.
Camargo M, Murphy G, Koriyama C, Pfeiffer R, Kim W, Herrera-Goepfert R, et al.
Br J Cancer
. 2011 Jun;
105(1):38-43.
PMID: 21654677
Background: Meta-analyses of the published literature indicate that about 9% of gastric cancers contain Epstein-Barr virus (EBV), with consistent and significant differences by sex and anatomic subsite. This study aimed...
10.
Sicinschi L, Correa P, Peek R, Camargo M, Piazuelo M, Romero-Gallo J, et al.
Clin Microbiol Infect
. 2009 May;
16(4):369-78.
PMID: 19456839
The C-terminus of the Helicobacter pylori CagA protein is polymorphic, bearing different EPIYA sequences (EPIYA-A, B, C or D), and one or more CagA multimerization (CM) motifs. The number of...